SEC Form 4 · accession 0001683168-17-002204
MEDICINOVA INC · MNOV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yoshio Ishizaka
Director
Period of report
Aug 21, 2017
Accepted (ET)
Aug 23, 2017 · 1:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001226616
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 21, 2017 | P | 5,000 | $5.17 | A | 10,000 | I | By Spouse |
| Common Stock | holding | — | — | — | 5,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported shares were purchased with Japanese Yen in multiple transactions. The purchase price reported in Column 4 is a weighted average price reflected in US Dollars, based on the applicable currency exchange rate in effect on the date of purchase, rounded to the nearest whole cent. The reporting person undertakes to provide to MediciNova, Inc., any security holder of MediciNova, Inc., or the staff of the Securities and Exchanges Commission, upon request, full information regarding the number of shares purchased at each separate prices.